Forest Laboratories Holdings, Ltd. et al v. Sandoz Inc. > Summary
Court Case Number 1:18-cv-00171
Filing Date Jan 30, 2018
Termination Date May 30, 2018
Court Delaware District Court
Status Dismissed - Settled
JudgesRichard G. Andrews
Defendant
Plaintiff Attorneys
19Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
ALLERGAN USA, INC.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Ironwood Pharmaceuticals
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Robert B. Wilson
Quinn Emanuel Urquhart & Sullivan
Allergan
Attorney Name: Anne S. Toker
Quinn Emanuel Urquhart & Sullivan
Allergan
Attorney Name: Krista M. Rycroft
Quinn Emanuel Urquhart & Sullivan
Allergan
Attorney Name: Gregory A. Morris
Honigman
Allergan
Attorney Name: Vikram A. Mathrani
Honigman
Allergan
Attorney Name: Simeon G. Papacostas
Honigman
ALLERGAN USA, INC.
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
ALLERGAN USA, INC.
Attorney Name: Robert B. Wilson
Quinn Emanuel Urquhart & Sullivan
ALLERGAN USA, INC.
Attorney Name: Anne S. Toker
Quinn Emanuel Urquhart & Sullivan
ALLERGAN USA, INC.
Attorney Name: Krista M. Rycroft
Quinn Emanuel Urquhart & Sullivan
Allergan
Attorney Name: Peter J. Armenio
Quinn Emanuel Urquhart & Sullivan
ALLERGAN USA, INC.
Attorney Name: Peter J. Armenio
Quinn Emanuel Urquhart & Sullivan
ALLERGAN USA, INC.
Attorney Name: Gregory A. Morris
Honigman
ALLERGAN USA, INC.
Attorney Name: Vikram A. Mathrani
Honigman
ALLERGAN USA, INC.
Attorney Name: Simeon G. Papacostas
Honigman
Defendant Attorneys
Sandoz
Attorney Name: John C. Phillips Jr.
Phillips, McLaughlin & Hall, P.A.
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09708371 | Treatments for gastrointestinal disorders | Jul 18, 2017 |
| 08933030 | Treatments for gastrointestinal disorders | Jan 13, 2015 |
| 08802628 | Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration | Aug 12, 2014 |
| 08748573 | Formulations comprising linaclotide | Jun 10, 2014 |
| 08110553 | Methods and compositions for the treatment of gastrointestinal disorders | Feb 7, 2012 |
